Development of an integrated conceptual model of multiple sclerosis spasticity

被引:2
|
作者
Cameron, Michelle H. [1 ]
Bethoux, Francois [2 ]
Field-Fote, Edelle [3 ,4 ]
Lenderking, William R. [5 ]
Zaiser, Erica [6 ]
Cutts, Katelyn N. [5 ]
Wagner, Joanne M. [7 ,8 ]
Berwaerts, Joris [7 ,8 ]
Steinerman, Joshua R. [9 ,10 ]
机构
[1] OR Hlth & Sci Univ, Dept Neurol, Portland, OR USA
[2] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH USA
[3] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA
[4] Emory Univ, Dept Rehabil Med, Sch Med, Atlanta, GA USA
[5] Evidera, Waltham, MA USA
[6] Evidera, London, England
[7] Greenwich Biosci Inc, Mt Prospect, IL USA
[8] Jazz Pharmaceut, Carlsbad, CA USA
[9] Jazz Pharmaceut Inc, Philadelphia, PA USA
[10] 2005 Market St,Suite 2100, Philadelphia, PA 19103 USA
关键词
Multiple sclerosis; muscle spasticity; conceptual model; qualitative research; interviews; SPINAL-CORD-INJURY; MOBILITY IMPROVEMENT; BOTULINUM TOXIN; SYMPTOMS; BURDEN; SATIVEX; DISEASE; STROKE; IMPACT; PAIN;
D O I
10.1080/09638288.2023.2237403
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
PurposeSpasticity is common in multiple sclerosis (MS), often leading to functional limitations and disability. We developed a conceptual model of spasticity in MS integrating expert opinion, recent literature, and experiences of clinicians and people with MS spasticity.MethodsA conceptual model was developed based on a targeted literature review of articles published between 2014 and 2019, followed by input from clinicians, then input from participants with MS spasticity. Multidisciplinary experts on spasticity provided guidance at each step.ResultsKey concepts of the integrated spasticity conceptual model included: moderators; triggers; modifiers; treatment; objective manifestations; subjective experience; physical, functional, social, and emotional/psychological impacts; and long-term consequences. Participants with MS spasticity most frequently endorsed spasms, tightness, and pain as descriptors of spasticity. Some participants with MS spasticity had difficulty distinguishing spasticity from other MS symptoms (e.g. muscle weakness). Some triggers, emotional/psychological impacts, and long-term consequences of spasticity reported by participants with MS spasticity were not previously identified in the published literature.ConclusionsThis conceptual model of spasticity, integrating published literature with the experience of clinicians, people with MS spasticity, and experts, demonstrates the complex, multidimensional nature of MS spasticity. This model may be used to improve clinician-patient dialogue, research, and patient care.
引用
收藏
页码:2955 / 2965
页数:11
相关论文
共 50 条
  • [21] Pain Treatment Beyond Spasticity: The Role of AbobotulinumtoxinA in the Rehabilitation of Multiple Sclerosis
    Baricich, Alessio
    Battaglia, Marco
    Cuneo, Daria
    Cosenza, Lucia
    Borg, Margherita Beatrice
    Loro, Alberto
    Millevolte, Marzia
    Cosma, Michela
    Filippetti, Mirko
    Dalise, Stefania
    Azzollini, Valentina
    Chisari, Carmelo
    Spina, Stefania
    Cinone, Nicoletta
    Scotti, Lorenza
    Invernizzi, Marco
    Paolucci, Stefano
    Picelli, Alessandro
    Santamato, Andrea
    TOXICON, 2024, 237 : 7 - 7
  • [22] Development and validation of Spasticity IndexAmyotrophic Lateral Sclerosis
    Milinis, K.
    Tennant, A.
    Mills, R. J.
    Al-Chalabi, A.
    Burke, G.
    Dick, D. J.
    Ealing, J.
    Hanemann, C. O.
    Harrower, T.
    McDermott, C. J.
    Majeed, T.
    Pinto, A.
    Talbot, K.
    Williams, T.
    Young, C. A.
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (01): : 47 - 54
  • [23] Costs and quality of life in multiple sclerosis patients with spasticity
    Svensson, J.
    Borg, S.
    Nilsson, P.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (01): : 13 - 20
  • [24] Spasticity in multiple sclerosis and role of glatiramer acetate treatment
    Eustasio Meca-Lallana, Jose
    Hernandez-Clares, Rocio
    Carreon-Guarnizo, Ester
    BRAIN AND BEHAVIOR, 2015, 5 (09):
  • [25] Spasticity, gait, and balance in patients with multiple sclerosis: A cross-sectional study
    Norbye, Anja Davis
    Midgard, Rune
    Thrane, Gyrd
    PHYSIOTHERAPY RESEARCH INTERNATIONAL, 2020, 25 (01)
  • [26] The contribution of cognition and spasticity to driving performance in multiple sclerosis
    Marcotte, Thomas A.
    Rosenthal, Theodore J.
    Roberts, Erica
    Lampinen, Sara
    Scott, J. Cobb
    Allen, R. Wade
    Corey-Bloom, Jody
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (09): : 1753 - 1758
  • [27] THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
    Sastre-Garriga, Jaume
    Vila, Carlos
    Clissold, Stephen
    Montalban, Xavier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (05) : 627 - 637
  • [28] Spasticity, ataxia and fatigue in multiple sclerosis
    Kesselring, J
    Thompson, AJ
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 429 - 445
  • [29] Pharmacologic management of spasticity in multiple sclerosis
    Pappalardo, A.
    Castiglione, A.
    Restivo, D. A.
    Calabrese, A.
    Cimino, V.
    Patti, F.
    NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 4) : S310 - S315
  • [30] Pharmacologic management of spasticity in multiple sclerosis
    A. Pappalardo
    A. Castiglione
    D. A. Restivo
    A. Calabrese
    V. Cimino
    F. Patti
    Neurological Sciences, 2006, 27 : s310 - s315